• Thurs news: GSK inks 2nd neuro pact in weeks. Teva episodic migraine trial. FDA clears AZ’s Imfinzi for aggressive lung cancer. Novartis fails to block generic Entresto. Nuvig gets immune drug funding. See more on our front page

Oticon

Anonymous board for Oticon
Opn
Replies
0
Views
3K
anonymous
Replies
1
Views
3K
anonymous